These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
887 related articles for article (PubMed ID: 32483109)
1. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study. Zhai X; Guo Y; Qian X Med Sci Monit; 2020 Jun; 26():e922675. PubMed ID: 32483109 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer. Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic ability of Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133 [TBL] [Abstract][Full Text] [Related]
4. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan. Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550 [TBL] [Abstract][Full Text] [Related]
5. Is FDG-PET/CT used correctly in the combined approach for nodal staging in NSCLC patients? Simsek FS; Comak A; Asik M; Kuslu D; Balci TA; Ulutas H; Koroglu R; Kekilli E; Akatli A; Elmali F; Yalcin NC; Akyol H Niger J Clin Pract; 2020 Jun; 23(6):842-847. PubMed ID: 32525121 [TBL] [Abstract][Full Text] [Related]
6. [ Li Y; Zhang Y; Guo Z; Hou P; Lv J; Ke M; Liu S; Li S; Yin W; He J; Wang X Cancer Imaging; 2024 Jun; 24(1):68. PubMed ID: 38831354 [TBL] [Abstract][Full Text] [Related]
7. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer. Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167 [TBL] [Abstract][Full Text] [Related]
8. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Schmidt-Hansen M; Baldwin DR; Hasler E; Zamora J; Abraira V; Roqué I Figuls M Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009519. PubMed ID: 25393718 [TBL] [Abstract][Full Text] [Related]
10. Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients. Shi YM; Niu R; Shao XL; Zhang FF; Shao XN; Wang JF; Wang XS; Liu B; Yu WJ; Wang YT Nucl Med Commun; 2020 May; 41(5):459-468. PubMed ID: 32187163 [TBL] [Abstract][Full Text] [Related]
11. Improving diagnostic performance of Yang DD; Mirvis E; Goldring J; Patel ARC; Wagner T Clin Radiol; 2019 Oct; 74(10):818.e17-818.e23. PubMed ID: 31420186 [TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non-small cell lung cancer. Hua J; Li L; Liu L; Liu Q; Liu Y; Chen X Nucl Med Commun; 2021 Nov; 42(11):1247-1253. PubMed ID: 34269750 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients. Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390 [TBL] [Abstract][Full Text] [Related]
14. Preliminary clinical assessment of dynamic Shinya T; Otomi Y; Kubo M; Kinoshita M; Takechi K; Uyama N; Yamanaka M; Terazawa K; Toba H; Bando Y; Otsuka H; Harada M Ann Nucl Med; 2019 Jun; 33(6):414-423. PubMed ID: 30911883 [TBL] [Abstract][Full Text] [Related]
15. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer. Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074 [TBL] [Abstract][Full Text] [Related]
16. The value on SUV-derived parameters assessed on Liao X; Liu M; Li S; Huang W; Guo C; Liu J; Xiong Y; Zhang J; Fan Y; Wang R BMC Med Imaging; 2023 Apr; 23(1):49. PubMed ID: 37020286 [TBL] [Abstract][Full Text] [Related]
17. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer. Muto J; Hida Y; Kaga K; Ohtaka K; Okamoto S; Tamaki N; Nakada-Kubota R; Hirano S; Matsui Y Anticancer Res; 2014 Feb; 34(2):805-10. PubMed ID: 24511016 [TBL] [Abstract][Full Text] [Related]
18. The value of net influx constant based on FDG PET/CT dynamic imaging in the differential diagnosis of metastatic from non-metastatic lymph nodes in lung cancer. Wumener X; Zhang Y; Zang Z; Ye X; Zhao J; Zhao J; Liang Y Ann Nucl Med; 2024 Nov; 38(11):904-912. PubMed ID: 39078558 [TBL] [Abstract][Full Text] [Related]
19. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer. Shigemoto Y; Suga K; Matsunaga N Ann Nucl Med; 2016 May; 30(4):287-97. PubMed ID: 27007128 [TBL] [Abstract][Full Text] [Related]
20. An Investigation of the Relationship Between Kandemir O; Demir F Curr Radiopharm; 2024; 17(1):111-116. PubMed ID: 37644744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]